Cargando…
Who, what, and when—effective therapy for severe COVID-19
Autores principales: | Kelmenson, Daniel A, Cron, Randy Q |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598210/ https://www.ncbi.nlm.nih.gov/pubmed/34812425 http://dx.doi.org/10.1016/S2665-9913(21)00353-2 |
Ejemplares similares
-
No perfect therapy for the imperfect COVID-19 cytokine storm
por: Cron, Randy Q
Publicado: (2022) -
COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021) -
Defining the scourge of COVID-19 hyperinflammatory syndrome
por: Cron, Randy Q, et al.
Publicado: (2020) -
Coronavirus is the trigger, but the immune response is deadly
por: Cron, Randy Q
Publicado: (2020) -
Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)